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Mycobacterium tuberculosis (Mtb) adapts to persist
in a nutritionally limited macrophage compartment.
Lipoamide dehydrogenase (Lpd), the third enzyme
(E3) in Mtb’s pyruvate dehydrogenase complex
(PDH), also serves as E1 of peroxynitrite reductase/
peroxidase (PNR/P), which helps Mtb resist host-
reactive nitrogen intermediates. In contrast to Mtb
lacking dihydrolipoamide acyltransferase (DlaT), the
E2 of PDH and PNR/P, Lpd-deficient Mtb is severely
attenuated in wild-type and immunodeficient mice.
This suggests that Lpd has a function that DlaT
does not share. When DlaT is absent, Mtb upregu-
lates an Lpd-dependent branched-chain keto acid
dehydrogenase (BCKADH) encoded by pdhA, pdhB,
pdhC, and lpdC. Without Lpd, Mtb cannot metabo-
lize branched-chain amino acids and potentially
toxic branched-chain intermediates accumulate.
Mtb deficient in both DlaT and PdhC phenocopies
Lpd-deficient Mtb. Thus, Mtb critically requires
BCKADH along with PDH and PNR/P for pathogen-
esis. These findings position Lpd as a potential target
for anti-infectives against Mtb.
INTRODUCTION
Most cases of tuberculosis are curable by drugs that have been
available for more than 40 years, yet Mtb is the single leading
cause of death from bacterial infection (Bloom and Murray,
1992). This medical-societal failure stems in part from using
anti-infectives that are chiefly active against replicating bacteria
to treat an infection in which many of the bacteria are not repli-
cating (McCune et al., 1966; Nathan, 2009; Nathan et al.,
2008). During a multi-decade innovation gap in anti-infective
drug development (Fischbach and Walsh, 2009), the inexorable
progression of drug resistance has made tuberculosis increas-
ingly harder to treat and sometimes untreatable (Chan et al.,
2008; Glaziou et al., 2009). Thus, a basic biologic question hasCellacquired urgent medical relevance: on what gene products
does Mtb depend for survival in the host? This is distinct from
how the question is usually framed in antibacterial drug develop-
ment: on what gene products does the pathogen depend for
survival in vitro?
Whether Mtb infection is latent or active, many of the bacilli
reside in macrophage phagosomes (Russell, 2001), where they
can sustain net rates of population growth near zero for long
periods (Gill et al., 2009; Munoz-Elias et al., 2005). Knowledge
is growing about the metabolic pathways required for survival
and persistence of intraphagosomal Mtb (Barry et al., 2009;
Smith, 2000). Mtb requires the enzymes isocitrate lyases 1 and
2 (encoded by icl1 and icl2 and serving the glyoxylate shunt
and methylcitrate cycle) to establish infection in the mouse
(Munoz-Elias and McKinney, 2005) and also needs genes
required for cholesterol metabolism to persist (Pandey and
Sassetti, 2008). Additionally, upregulation of gluconeogenic
and glyoxylate shunt genes in Mtb recovered from mouse
macrophages (Schnappinger et al., 2003), mouse lungs, and
patient specimens (Timm et al., 2003) suggests that to survive
in the host, Mtb must metabolize acetyl coenzyme A (coA) in
an anaplerotic fashion. It has been assumed that this reflects
the derivation of acetyl coA from b-oxidation of fatty acids
(Munoz-Elias and McKinney, 2006).
Anabolism of the branched-chain amino acids leucine, isoleu-
cine, and valine has been well studied in Mtb and pathways
responsible for their synthesis are essential for virulence (Honda-
lus et al., 2000). However, little attention has been given to their
catabolism, which might serve to prevent their overaccumula-
tion, facilitate the generation of branched-chain fatty acids, or
provide energy.
One aspect of host-immune chemistry that contributes
substantially to Mtb’s nonreplication in vivo is the generation of
reactive nitrogen intermediates (RNI) by inducible nitric oxide
synthase (iNOS) (MacMicking et al., 1997). RNI can kill bacteria
by forming intrabacterial peroxynitrite (St John et al., 2001).
Accordingly, we searched for enzymes that permit Mtb to
survive exposure to RNI. We discovered a PNR/P consisting of
four enzymes: Lpd, encoded by lpdC (Rv0462) (Argyrou and
Blanchard, 2001); DlaT; a thioredoxin-like protein, AhpD; and
the peroxiredoxin AhpC (Bryk et al., 2000, 2002). Enzymes that
function in complexes are often designated ‘‘E1,’’ ‘‘E2,’’ etc. inHost & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inc. 21
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Figure 1. Characterization of Lpd-Deficient Mtb In Vitro
(A) Western blot analysis of wild-type (H37Rv), mutant (DlpdC), and comple-
mented (H37RvDlpdC::lpdC) strains with antiserum against Lpd. Anti-DlaT
was used to assess equal loading.
(B) Growth curve in bacteriologic medium containing dextrose and glycerol as
the sole carbon sources.
(C) Survival of strains after 4 days exposure to NaNO2 at pH 5.5. Means ± stan-
dard deviation (SD) of triplicate experimental samples are shown from one
experiment, representative of three.
(D) Survival of strains upon exposure to increasing concentrations of H2O2 for
4 hr.Means ±SDof triplicate experimental samples are shown fromone exper-
iment, representative of two.
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Mtb Virulence Depends on Lipoamide Dehydrogenasethe order of sequential catalysis. Lpd was originally predicted to
serve as the last enzyme (E3) in two complexes, a-ketoglutarate
dehydrogenase (aKGDH) and PDH in Mtb (Cole and Barrell,
1998). However, we found that Mtb lacks aKGDH (Tian et al.,
2005a) and that the E1 and E2 of PDH are products of aceE
and dlaT (Tian et al., 2005b), the latter originally misannotated
as E2 of aKGDH. This left unexplained the functions of the
proteins encoded by the genes pdhA (Rv2497c, annotated as
the a subunit of E1 of PDH), pdhB (Rv2496c, annotated as the
b subunit of E1 of PDH) and pdhC (Rv2495c, annotated as E2
of PDH). In many organisms Lpd is also the E3 of BCKADH, so
we hypothesized that the pdhABC operon may encode the E1
and E2 of BCKADH (Tian et al., 2005b). However, we could
detect no such activity in Mtb (Tian et al., 2005b).
Deletion of dlaT had a pronounced effect on Mtb’s growth in
standard medium in vitro, sensitized Mtb to RNI, and attenuated
Mtb in the mouse (Shi and Ehrt, 2006). Additionally, species-
selective DlaT inhibitors selectively killed nonreplicating Mtb
(Bryk et al., 2008). We then focused on Lpd as a potential target,
because it participates in the same two enzyme complexes as
DlaT, namely PDH and PNR/P (Bryk et al., 2000, 2002). Structural
differences between the active sites of human and mycobacte-
rial Lpd (Rajashankar et al., 2005) were exploited in the develop-
ment of species-selective inhibitors of mycobacterial Lpd (Bryk
et al., 2010). In the course of these studies we were surprised
to discover that Lpd-deficient Mtb was far more attenuated
in vivo than DlaT-deficient Mtb. This led us to search for yet
another function of Lpd. The findings add to our understanding
of host-pathogen interactions in experimental tuberculosis.
RESULTS
Mtb Requires Lpd for Virulence
We disrupted lpdC in Mtb H37Rv by homologous recombination
and confirmed the deletion by Southern blot (see Figure S1A,
available online), mRNA analysis (see Figure S1B) and western
blot (Figure 1A). We reintroduced lpdC via complementation in
an integrative vector driven by a constitutive hsp60 promoter
and achieved wild-type expression levels of LpdmRNA (see Fig-
ure S1B) and protein (Figure 1A). As will be shown subsequently,
the Lpd-deficient strain grew, albeit poorly, in standard medium
with dextrose, glycerol, and fatty acids as carbon sources. To
confirm Lpd’s role in metabolism of carbohydrates through its
participation in PDH, we monitored the growth of wild-type,
mutant, and complemented bacteria with glycerol and dextrose
as the only carbon sources. As predicted, the Lpd-deficient
bacteria failed to grow on carbohydrates, while the wild-type
and complemented strains grew normally (Figure 1B). The Lpd-
containing PNR/P detoxifies peroxynitrite but not NO (Bryk
et al., 2000, 2002). Killing of bacteria by mildly acidified nitrite
or other NO donors requires oxygen and involves oxidation of
intrabacterial peptidyl methionine (St John et al., 2001), strongly
suggesting that it proceeds through intrabacterial conversion of
NO (a nonoxidizing species) to peroxynitrite (a strong oxidant).
Thus, to test Lpd’s role in PNR/P, we exposed the three strains
to mildly acidified nitrite. The Lpd-deficient bacteria lost three
log10 colony-forming units (CFUs) at concentrations of nitrite
that reduced the viability of the wild-type and complemented
strains by only <0.5 log10 (Figure 1C), consistent with Lpd’s22 Cell Host & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inrole in PNR/P. To determine whether Mtb lacking lpdC was
specifically resistant to the stresses imposed, or merely sickly,
we exposed wild-type, mutant, and complemented strains to
oxidative stress in the form of H2O2. Mtb lacking lpdC was
more resistant thanwild-type and complemented strains, a prop-
erty shared by several other Mtb mutants that are more sensitive
to RNI in vitro (Darwin et al., 2003; Gandotra et al., 2007)
(Figure 1D).
Next we assessed the role of Lpd in Mtb’s ability to grow and
persist in vivo by infecting C57BL/6 mice with Lpd-deficient Mtb
or the wild-type or complemented strains. The mutant strain was
rapidly cleared from the lungs (Figure 2A) and either never
seeded the spleen or failed to survive there (Figure 2B). Because
we plated the organs in their entirety, the detection limit in our
assays was one CFU/organ. Nondetection of CFU did not result
from toxicity of lung homogenates to the bacteria, because the
expected number of CFU was observed by using the same
homogenization procedure on the first day after infection. Lungs
contained no detectable CFU in most of the mice from day 7
through termination of the experiment at day 164 and spleens
contained no CFU at any time tested (days 28, 64, and 164).c.
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Figure 2. Mtb Requires Lpd for Virulence in Both Wild-Type and
IFNg–/– Mice and in Macrophages
(A, B) Fate of Mtb strains in C57BL/6 mice in (A) lungs and (B) spleens after
aerosol infection. Means ± SD for four mice per point are shown from one
experiment, representative of three.
(C) Gross pathology of lungs was recorded at day 164 postinfection.
(D) Survival of Mtb strains in mice lacking IFNg. Means ± SD are shown from
one experiment for four mice per point.
(E, F) Survival in naive (E) and IFNg-activated (F) macrophages of the above
Mtb strains, as well as in Mtb lacking dlaT. Means ± SD of triplicate experi-
mental samples are shown from one experiment, representative of two.
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played no gross or microscopic pathology (Figure 2C and Fig-
ure S2). Complementation of the mutant restored virulence
in vivo, confirming that the severe attenuation of the mutant
in vivo was due to loss of lpdC.
Infection with Mtb elicits IFNg production first by natural killer
(NK) cells and then by T lymphocytes. IFNg is critically required
for control of Mtb infection in both mice and humans (Flynn
et al., 1993; Jouanguy et al., 1997; Zhang et al., 2008). To test
whether Mtb lacking lpdC requires IFNg-dependent immunity
for clearance of the bacterium, we infected IFNg/ mice.
IFNg/ mice infected with the lpdC mutant rapidly cleared the
infection, while those infected with wild-type Mtb were highly
susceptible (Figure 2D).
Consistent with the rapid clearance of Lpd-deficient Mtb
in vivo, bone marrow-derived macrophages from C56BL/6Cellmice killed the lpdCmutant by5 fold evenwithout immunologic
activation, while the wild-type and complemented strains grew
1.5 log10 over the same period (Figure 2E). Whenmacrophages
were activated with IFNg and then infected, the lpdCmutant was
killed by 1 log10 while the wild-type and complemented strains
still grew, albeit more slowly than in naive macrophages (Fig-
ure 2F). The lesser effect of IFNg in these experiments than
in earlier studies (e.g., Shi and Ehrt, 2006) was associated
with use of different IFNg preparations and our current practice
of omitting all antibiotics during the differentiation of the
macrophages.
Metabolic Differences between DlaT-Deficient
and Lpd-Deficient Mtb
Characterization of DlaT-deficient Mtb in the samemousemodel
had revealed only a 1.5 log10 reduction in CFU in the lungs at the
onset of the chronic stage of the infection compared to wild-type
Mtb (Shi and Ehrt, 2006). The R6 log10 attenuation that we
observed herewith Lpd-deficientMtb suggested that Lpd serves
an important function in Mtb in which DlaT does not participate.
Lpd-deficient and DlaT-deficient mutants were almost indistin-
guishable in their survival during exposure to a cell-wall-perturb-
ing agent (SDS) (see Figure S3A) or lipophilic antibiotics (see
Figures S3B–S3D). Both mutants, however, were more resistant
to ethambutol and rifampicin than wild-type Mtb, possibly
because of the impaired replication of these strains.
However, compared to DlaT-deficient Mtb, Lpd-deficient Mtb
had an inferior capacity for extended growth in 7H9medium (Fig-
ure 3A). Along with carbohydrates, 7H9 medium provides fatty
acids when it is supplemented in the standard manner with the
dispersal agent Tween 80 (an oleic acid polymer) and bovine
serum albumin (a fatty acid carrier). The lpdC mutant did not
merely cease growth at later time points, but died, as reflected
by1 log loss of CFU, while wild-type, DlaT–deficient, and com-
plemented Mtb continued to survive in stationary phase (Fig-
ure 3B). Removing dextrose and glycerol impaired the growth
of wild-type Mtb as well as the dlaT mutant so that their growth
rates became almost indistinguishable from that of the lpdC
mutant (Figure 3C). This suggested that when carbohydrates
were present, DlaT-deficient Mtb may have metabolized carbo-
hydrates along with the fatty acids, while Lpd-deficient Mtb may
have subsisted only on the fatty acids.
In order to elucidate a potential mechanism by which the dlaT
mutant, despite lacking PDH, was able to use carbohydrates, we
quantified several intracellular metabolites in wild-type and
mutant bacteria. Inhibition of PDH by genetic deletion of either
lpdC or dlaT is expected to lead to a buildup of glycolytic inter-
mediates and pyruvate (Bryk et al., 2008). We grew the wild-
type, mutant, and complemented strains on filter discs on 7H9
agar plates to facilitate rapid harvest and to avoid losing the
metabolites that leak during handling (de Carvalho et al.,
2010a, 2010b) and analyzed metabolites in their lysates by liquid
chromatography-mass spectrometry. At week 2 of in vitro
culture, by which time the lpdC and dlaT mutants had grown to
a similar extent, pyruvate was comparably elevated in both
mutant strains compared to wild-type and complemented
strains (Figure 4A). Alanine, a metabolite of pyruvate, was also
elevated in both mutant strains (see Figure S4A). The
branched-chain amino acids valine, leucine, and isoleucine canHost & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inc. 23
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Figure 4. Dysregulation of Intracellular Metabolite Pools in Wild-
Type, Mutant, and Complemented Strains
(A–D) Levels of intracellular pyruvate (A), ketovaline (B), ketoleucine + ketoiso-
leucine (C), and histidine (D) in wild-type, mutant, and complemented strains.
Means ± SD for metabolite data of triplicate experimental samples are shown
from one experiment, representative of two. *p < 0.02.
(E, F) Growth of strains in 7H9 medium containing 0.2% (w/v) leucine (E) or
0.2% (w/v) isoleucine (F) as the sole carbon sources. Growth curves are repre-
sentative of at least three experiments.
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Figure 3. Mtb Lacking dlaT Grows and Survives Better Than Mtb
Lacking lpdC
(A) Growth of wild-type, mutants (DlpdC, DdlaT), and complemented strains
(DlpdC::lpdC, DdlaT::dlaT) in complete 7H9 medium.
(B) Survival of the same strains as measured by change in CFUs. Means ± SD
are shown of triplicate cultures.
(C) Growth in 7H9 containing no carbohydrate carbon sources. All results are
representative of at least two independent experiments.
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day 14 in both mutant strains compared to wild-type and
complemented strains (see Figures S4B–S4D). Metabolism of
branched-chain amino acids results in generation of branched-
chain keto acids, which are direct substrates for the BCKADH
complex. The intracellular levels of ketovaline, ketoleucine, and
ketoisoleucine were similarly elevated in both mutant strains
compared to wild-type and complemented strains (Figures 4B
and 4C). In contrast, histidine, whosemetabolism is independent
of PDH, was equally abundant in all five strains (Figure 4D). At
day 28, when the dlaT mutant had continued to grow but the
lpdC mutant had stopped growing, intracellular pyruvate,
leucine, isoleucine, valine, and their keto acid metabolites
returned to near normal levels in the dlaT mutant, suggesting
that they had been metabolized. However, these metabolites
all remained elevated in Mtb lacking lpdC (Figures 4A–4C and
Figures S4A–S4D), while histidine remained constant (Figure 4D).
The reduction in levels of ketoleucine and/or ketoisoleucine in
the dlaT mutant from day 14 to day 28 (p = 0.0026 for the differ-
ence between the two time points) brought the level nearly to that
of the wild-type strain. In contrast, there was a much smaller
reduction in levels in the lpdCmutant (p = 0.01 for the difference
between the two time points). As noted, complementation of the
mutant strains partially or completely restored levels of metabo-
lites to wild-type levels (Figures 4A–4D and Figures S4A–S4D).
Thus, early in culture, both DlaT-deficient Mtb and Lpd-deficient
Mtb gave metabolic evidence of their PDH deficiency. However,
between the second and fourth weeks of culture, the metabolic24 Cell Host & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inprofile of DlaT-deficient Mtb and Lpd-deficient Mtb diverged.
DlaT-deficient Mtb appeared to acquire the ability to overcome
the block in metabolite flux, while Lpd-deficient Mtb did not.
Consistent with this, Mtb lacking DlaT grew on leucine (Fig-
ure 4E) and isoleucine (Figure 4F) even better than wild-type
and complemented strains. In contrast, Mtb lacking Lpd was
unable to grow on leucine or isoleucine. In this respect, Lpd-defi-
cient Mtb phenocopied Mtb lacking both Icl1 and Icl2 (see
Figures S4E and S4F). Thus, both Lpd and the methylcitrate
cycle and/or glyoxylate shunt are required for growth on
branched-chain amino acids. In contrast, absence of DlaT
augmented the ability of Mtb to grow on these substrates,
perhaps by forcing Mtb to express an Lpd-dependent enzyme
that metabolizes them. Neither the mutants nor wild-type Mtb
was able to grow on valine.
Appearance of BCKADH in PDH-Deficient Mtb
To identify proteins that complex with Lpd in different circum-
stances, we generated Lpd tagged with octapeptide and
hemagglutinin (FLAG-HA) and introduced it into both the lpdCc.
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Figure 5. Characterization of BCKADH
Complex in Mtb
(A) Immunoblot (IB) of the immunoprecipitate from
the DlpdC::FLAGlpdC and the DdlaT::FLAGlpdC
strains by using antisera against DlaT, lipoic acid
(LA), and PdhC.
(B) Western blot of lysates from wild-type and
mutant strains collected at day 28 postinoculation
at OD580 = 0.02 by using antisera against Lpd,
DlaT, LA, PdhC, and PrcB, used as a loading
control. Immunoprecipitations and western blots
were performed at least twice.
(C) Levels of pdhA and pdhC transcripts assessed
by qRT-PCR at indicated time points in wild-type
and mutant strains. Results show means ± SD of
one sample from three individual experiments,
normalized to fold above sigA.
(D–F) In vitro BCKADH activity in lysates prepared
from DlaT-deficient Mtb (D), wild-type Mtb (E), and
Lpd-deficient Mtb (F). Results are representative of
two experiments.
Cell Host & Microbe
Mtb Virulence Depends on Lipoamide Dehydrogenaseand dlaT mutants (DlpdC::FLAGlpdC and DdlaT::FLAGlpdC).
FLAG-HA-tagged Lpd restored growth of the lpdC mutant in
7H9 medium to wild-type levels, suggesting that the tag did
not interfere with Lpd’s functional associations. Introduction of
FLAG-HA-tagged Lpd into the dlaT mutant had no discernible
effect on its growth (see Figure S5A). After 28 days of growth
in 7H9 medium, we lysed the bacteria and immunoprecipitated
Lpd with a-FLAG antibody. E2’s of keto acid dehydrogenase
complexes require lipoic acid as a prosthetic group (Perham,
2000). In earlier work, DlaT was the only lipoylated protein
we could detect in wild-type Mtb (Bryk et al., 2002). In
DlpdC::FLAGlpdC, DlaT was the major interacting partner of
Lpd and was again the only lipoylated protein observed in the
immunoprecipitate (Figure 5A). In contrast, in the DdlaT::
FLAGlpdC strain, Lpd coimmunoprecipitated with PdhA, PdhB,
and PdhC, as identified by peptide mass fingerprinting (see
Table S1). An antibody we raised against pure, recombinant
PdhC immunoblotted a protein in the latter immunoprecipitate
that migrated at 42 kDa, as expected for PdhC. The anti-PdhC
antibody reacted with nothing in a control immunoprecipitateCell Host & Microbe 9, 21–3prepared from lysates of DdlaT Mtb in
which native LpdC did not carry the
FLAG epitope (Figure 5A). The results
with anti-PdhC antibody strongly rein-
forced the mass spectroscopic evidence
that PdhC associates specifically with
LpdC. Finally, in the anti-LpdC-FLAG
immunoprecipitates from lysates of DdlaT
Mtb, a protein distinct from DlaT became
lipolyated and it comigrated with PdhC
(Figure 5A).
Next, we monitored the status of
protein lipoylation in the total lysates of
Mtb strains rather than only in Lpd-
interacting proteins, again focusing on
28 day cultures. In DlaT-deficient Mtb,
we detected only one lipolylated protein.It migrated at 42 KDa and comigrated with the upper band in
the doublet immunoblotted by anti-PdhC (Figure 5B). The lower
band in the doublet thus corresponds to PdhC that was not
lipoylated. Although there was a nonlipoylated fraction of PdhC
in Mtb lysates, the PdhC recovered from anti-Lpd immunopre-
cipitates migrated as a singlet (Figure 5A). These observations
suggest that only lipoylated PdhC binds LpdC. In contrast,
only DlaT was lipoylated in wild-type and Lpd-deficient Mtb.
Moreover, the level of PdhC in DlaT-deficient Mtb appeared to
be higher than in wild-type Mtb or Lpd-deficient Mtb. Consistent
with this, transcripts for pdhA and pdhC were 8-fold higher in
DlaT-deficient Mtb than in wild-type and Lpd-deficient strains
(Figure 5C). Deep sequencing of the transcriptomes of wild-
type and DlaT-deficient Mtb revealed that pdhA, pdhB, and
pdhC were the most highly upregulated genes in the dlaT
mutant, being expressed at levels 14.3-, 12.5- and 12.5-fold,
respectively, higher than the levels in wild-type Mtb (R.B.,
unpublished observations). We amplified cDNA across the junc-
tions of pdhA-B and pdhB-C and verified that pdhABC are tran-
scribed as an operon (see Figure S5B).1, January 20, 2011 ª2011 Elsevier Inc. 25
AB C D
E
Figure 6. Characterization of an Mtb Mutant
Lacking Both dlaT and pdhC
(A) Western blot of wild-type, DdlaT, DpdhC,
DdlaTDpdhC, and the complemented strain
(DdlaTDpdhC::dlaT) was performed by using anti-
sera against DlaT, PdhC, Lpd, and PrcB.
(B–D) Growth curve of the above strains as well as
Mtb lacking lpdC, in complete 7H9 medium (B),
medium containing leucine (C), or medium contain-
ing isoleucine (D) as the sole carbon source.
(E) Survival of wild-type, DdlaTDpdhC, DlpdC,
DdlaT, and DdlaTDpdhC::dlaT strains in lungs of
C57BL/6 mice infected via aerosol. Means ± SD
for four mice per Mtb strain are shown from one
experiment, representative of at least two.
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cultures of DlaT-deficient Mtb with 3-methyl 2-oxobutyrate
(3M2OB) as a substrate (Figure 5D). Lysates from wild-type, Lpd-
deficient, and DlaT-complemented strains showed no BCKADH
activity (Figures 5E and 5F and Figure S5C). Lysates from 14 day
wild-type and DlpdC cultures lacked BCKADH activity, while
lysates from 14 day DdlaT cultures showed very low levels of
BCKADHactivity (seeFigureS5D).Asacontrol,wealsomeasured
PDHactivity inwild-typeandmutant lysates.Asexpected,only the
wild-type strain carried out this reaction (see Figure S5E).
Thus, in the absence of DlaT, Mtb upregulated pdhABC,
expressed readily detectable quantities of lipoylated PdhC in
complex with Lpd, and acquired the ability to metabolize
branched-chain keto acids.
Recapitulation of Lpd Deficiency by Double Deficiency
of DlaT and PdhC
To help confirm the foregoing interpretations, we deleted pdhC
from H37Rv, generating DpdhC, and from H37RvDdlaT, gener-26 Cell Host & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inc.ating DdlaTDpdhC. We confirmed the
disruption of pdhC by western (Figure 6A)
and Southern blotting and qRT-PCR (see
Figures S6A and S6B). The strain
DdlaTDpdhC was severely attenuated in
its ability to grow in 7H9 containing glyc-
erol and dextrose, as well as on leucine
or isoleucine, thus phenocopying DlpdC.
The strain lacking only PdhC did not
appear to have a growth defect in any of
these conditions, suggesting that when
PdhC is missing, these substrates may
be metabolized via PDH. Only when the
E2’s of PDH and BCKADH were both
missing did it appear that glycolytic and
branched-chain carbon sources could no
longer be metabolized. Introduction of
a single copy of the dlaT gene into
DdlaTDpdhC, generating DdlaTDpdhC::
dlaT, complemented all growth pheno-
types to wild-type levels (Figures 6B–6D).
Finally, we infected C57BL/6 mice with
both the DpdhC and the DdlaTDpdhCmutants. As controls, we also infected mice with DdlaTDpdhC::
dlaT, DlpdC, or DdlaT. The DpdhC mutant resembled wild-
type Mtb (see Figure S6C) in its virulence. Reproducibly,
the DdlaTDpdhC strain could not be recovered at day 1,
despite equal input into the aerosolizer. However, by day 7,
the DdlaTDpdhC and DlpdC mutants were both recovered
at 100 CFUs. This suggests that the DdlaTDpdhC mutant
was viable but nonculturable at day 1 for unknown reasons.
At day 35, the DlpdC strain could no longer be recovered.
At that point, and at day 190, the DdlaTDpdhC mutant was
2–3 log more attenuated than the DdlaT mutant but more
virulent than the DlpdC mutant. Complementation of the
double knockout with dlaT restored wild-type virulence
levels (Figure 6E). Thus, both PDH and BCKADH complexes
are jointly required for virulence of Mtb. However, the
finding that the DdlaTDpdhC mutant was not as attenuated as
the DlpdC mutant suggests Lpd may play a fourth important
role over and above its contributions to PDH, BCKADH, and
PNR/P.
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This work sheds light on three facets of our understanding of
host-pathogen interactions in experimental tuberculosis: how
we assess the nutritional composition of the host niche; how
a pathogen adapts to nutritional challenges; and how targets
are validated in the search for anti-infectives that hold promise
to be effective against Mtb in the host.
One major avenue in the study of host-pathogen relationships
is to infer the properties of the pathogen’s survival and growth
niches in the host by assessing the phenotype of the pathogen
when specific enzymes have been knocked out. Attenuation by
knockout of a metabolic enzyme is often interpreted to mean
that the pathogen must subsist in the host on that enzyme’s
substrate(s). This line of reasoning requires two key inputs: an
accurate understanding of what reactions the enzyme catalyzes,
which may be different from what was expected; and an assess-
ment of whether the phenotype may reflect not lack of the
enzyme’s products, but rather, intoxication by substrates that
accumulate in its absence. The extent to which metabolic
substrates will actually accumulate in the absence of a given
enzyme is difficult to predict. Most metabolites lie on multiple
enzymatic pathways. We have insufficient knowledge of alterna-
tive pathways and their rate constants, particularly in the setting
where one major route is inactivated and others may then be
adaptively modulated, not only by transcription but also by
changes in negative and positive feedback by substrates and
products.
For example, Mtb is severely attenuated in the mouse by
combined inactivation of icl1 and icl2 (Munoz-Elias and
McKinney, 2005). While this was initially interpreted as reporting
that Mtb subsists in vivo on fatty acids, subsequent in vitro
studies with mutants of M. smegmatis cultured on various
carbon sources led to an alternative interpretation, that poor
survival of Mtb lacking Icl1 and Icl2 may reflect intoxication by
accumulation of propionate and its metabolites (Upton and
McKinney, 2007). That disruption of a gene encoding an enzyme
can prove lethal from accumulation of toxic precursors was
recently demonstrated for the Mtb maltosyltransferase encoded
by glgE (Kalscheuer et al., 2010). Similarly, Pethe et al. identified
pyrimidine imidazoles that killed Mtb in vitro by promoting accu-
mulation of glycerol phosphate in a standard growth medium
containing glycerol (Pethe et al., 2010).
Although Mtb requires leucine to survive, excess leucine in the
growth medium proved toxic (data not shown). This is reminis-
cent of maple syrup urine disease, an autosomal recessive
disorder of humans in which insufficiency of BCKADH leads to
accumulation of toxic levels of branched-chain amino keto acids
(Mackenzie and Woolf, 1959). In the present work, disruption of
lpdC led to extraordinary accumulations of pyruvate and
branched-chain amino and keto acids. These accumulations
may cause this strain’s marked attenuation. Metabolomic anal-
ysis was invaluable for allowing us to recognize this possibility.
Thus, the first implication of our findings is that metabolomic
analysis provides an important complement to gene knockout
studies in research aimed at inferring the nutritional composition
of the pathogen’s niche in the host.
Another fundamental goal of studying host-pathogen interac-
tions is to understand the molecular basis of the pathogen’sCelladaptability to changing conditions. Adaptability is critical to
pathogenesis, both when the pathogen changes niches upon
infecting a new host and when the host responds to infection
in ways that alter the niche. The present work has demonstrated
a remarkably slow, extremely specific and functionally important
adaptation by Mtb that consists in switching lipoylation from
one protein substrate to an alternative protein substrate. Thus,
when the E2 of PDH was genetically deleted, Mtb upregulated
pdhABC, accumulated lipolyated PdhC, and expressed a
BCKADH whose function was evident in the distribution of
metabolites and the activity of lysates. In light of these findings,
Rv2497c, Rv2496c, and Rv2495c can be reannotated as bkdA,
bkdB, and bkdC, respectively. In contrast, wild-type and Lpd-
deficient Mtb grown on a standard rich medium in vitro either
did not express a functional BCKADH complex or expressed it
at levels below our ability to detect it.
Yet another important goal of studying host-pathogen interac-
tions is to guide the development of anti-infectives that are
effective in vivo because they cripple pathways on which the
pathogen actually depends in vivo. This has been difficult to
predict from studies in vitro. A pathway can be essential
in vitro but not in vivo (Pethe et al., 2010), or essential in vivo
but not in vitro (Munoz-Elias and McKinney, 2005). Thus, it is
important to learn that DlpdC Mtb was markedly attenuated
in vivo. This could not have been predicted from our limited
understanding of central carbon metabolism in Mtb.
It has commonly been thought that intermediarymetabolism in
Mtb mirrors that in other organisms and is therefore well under-
stood. In fact, Mtb’s core intermediary metabolism diverges
markedly from the standard model. For example, the tricarbox-
ylic acid cycle is interrupted by the lack of aKGDH (Tian et al.,
2005b). A unique anaerobic-type but aerobically active ferre-
doxin oxidoreductase acts on a-ketoglutarate (Baughn et al.,
2009) but metabolomic analysis does not support the interpreta-
tion that the oxidative and reductive arms of the tricarboxylic
acid cycle are fully joined (de Carvalho et al., 2010a, 2010b).
Additionally, the pentose-phosphate pathway and tricarboxylic
acid cycle in Mtb are extensively compartmentalized from each
other (de Carvalho et al., 2010a. In short, core intermediary
metabolism in Mtb is vitally important but incompletely under-
stood. Combining the tools of genetics, biochemistry, metabolo-
mics, and infections can help fill this gap.
We were surprised to discover that Mtb was more attenuated
by lack of Lpd than by lack of DlaT or even by lack of both DlaT
and PdhC. Lpd clearly has important functions that it does not
share with DlaT. At present, participation in BCKADH is the
only such function identified. Transcription of bkdABC was
detected in Mtb recovered from lungs of mice but only at the
same low level as in Mtb grown in rich medium in vitro (Talaat
et al., 2004). This leaves open the question whether BCKADH
is expressed at the protein level to an extent that can contribute
to the metabolism of PDH-replete Mtb during infection of the
mouse or only plays a role when it is upregulated, for example,
in the context of insufficient PDH activity. In either setting,
BCKADH might be critical to Mtb’s survival for several reasons.
Above, we stressed the role of BCKADH in avoiding accumula-
tion of pyruvate, branched-chain amino acids, and branched-
chain keto acids. Additionally or alternatively, in glucose-limiting
conditions in vivo, Mtb may operate a phosphoenol pyruvateHost & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Inc. 27
Figure 7. Schematic Showing Roles of Lpd in PDH, BCKADH, and
PNR/P Complexes in Mtb
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(Fischer and Sauer, 2003; Munoz-Elias and McKinney, 2006).
In the absence of PDH, BCKADH may be able to shunt metabo-
lites from pyruvate to acetyl coA, as is required for the func-
tioning of the PEP-glyoxylate pathway. In vitro, carbon-starved
Mtb upregulated transcripts for bkdA, bkdB, bkdC, and icl1
(Betts et al., 2002). Thus, when otherwise facing starvation,
Mtb may metabolize branched-chain keto and amino acids via
BCKADH as a source of energy. Finally, BCKADHmay help regu-
late the levels of branched-chain lipids. Inactivation of the
BCKADH complex in Staphylococcus aureus and Myxococcus
xanthus led to a decrease in quantity of branched-chain fatty
acids in the cell membrane and rendered the mutants more
susceptible to a variety of stresses (Singh et al., 2008; Toal
et al., 1995). Changes in Mtb’s branched-chain fatty acids like-
wise affect Mtb’s virulence (Glickman and Jacobs, 2001).
Thus, the present work establishes the contribution of LpdC to
BCKADH in Mtb and the essentiality of LpdC for Mtb’s virulence
in the mouse. However, it is not yet clear how BCKADH contrib-
utes to Mtb’s virulence.
The essentiality of mycobacterial Lpd in the mouse and the
participation of this one protein in at least three different enzyme
complexes (Figure 7) suggest that Lpd might be a promising
target for chemotherapy of tuberculosis. The triazospirodi-
methoxybenzoyl inhibitor that inhibits Mtb’s Lpd while sparing
human Lpd was not able to enter intact Mtb but its identification
demonstrates that species-selective Lpd inhibition is attainable
(Bryk et al., 2010).EXPERIMENTAL PROCEDURES
Strains and Culture Conditions
Wild-type Mtb H37Rv, mutants, and complemented strains were cultured at
37C inMiddlebrook 7H9with 0.2%glycerol, 0.5%bovine serum albumin frac-
tion V (BSA), 0.05% Tween 80, 0.2% dextrose, and 0.085% NaCl (standard
medium). Studies on defined carbon sources (0.2%) used fatty acid-stripped
BSA (Roche) without glycerol and dextrose with tyloxapol (0.02%) and vitamin
B12 (10 mg/ml) (Savvi et al., 2008). CFUs were determined on 7H11 agar plates
after 4 weeks at 37C. Strains bearing antibiotic resistance cassettes were
cultured in the presence of hygromycin (50 mg/ml), kanamycin (30 mg/ml),
streptomycin (30 mg/ml), or zeocin (25 mg/ml). For growth on solid medium,
Middlebrook 7H11 was supplemented with 0.5% glycerol and 10% oleic
acid-dextrose-catalase (7H11-OADC).
Mutant Strains
Efforts to delete lpdC (Rv0462, lpdC) from the genome of Mtb H37Rv were
initially unsuccessful. We cloned lpdC into an integrative complementation
vector (pMV306k) downstream of a constitutively active hsp60 promoter.
pMV306k-hsp60lpdCwas transformed into wild-type H37Rv to create amero-
diploid strain carrying lpdC at its native site as well as at the attB site
(H37Rv::lpdC). LpdC was deleted from the native site of the H37Rv merodi-
ploid strain via a single-step recombination with the mycobacteriophage
pHAE87 (Bardarov et al., 1997). Five hundred and fifty base pairs (bp)
upstream and 500 bp downstream of lpdC were cloned into the plasmid
pJSC284 flanking a hygromycin resistance cassette. The recombinant myco-
bacteriophage was used to infect H37Rv::lpdC. Knockout colonies were
screened by PCR and confirmed by Southern blotting. The complementing
plasmid was switched out of the attB site with an empty plasmid bearing
a streptomycin resistance cassette, pTCS-mcs1, creating H37RvDlpdC
pTCS-mcs1 (H37RvDlpdC).
To construct FLAG-HA tagged lpdC, we fused an N-terminal FLAG-HA tag
(codon optimized for use inMtb) to lpdC by PCR, deleting the N-terminal valine
of Lpd (FLAG-Lpd). This was cloned into an episomal plasmid, pTEK-hsp60,28 Cell Host & Microbe 9, 21–31, January 20, 2011 ª2011 Elsevier Indownstream of the hsp60 promoter. pTEK hsp60 nFLAG-HAlpdC was
transformed into H37RvDlpdC (DlpdC::FLAGlpdC) and H37RvDdlaT (DdlaT::
FLAGlpdC).
PdhC (Rv2495c) was deleted via single-step recombination by using themy-
cobacteriophage pHAE87 with a streptomycin resistance cassette. Regions
flanking pdhC (727 bp upstream, 717 bp downstream) were cloned on
either side of the streptomycin cassette. The recombinant mycobacterio-
phage infected H37Rv and H37RvDdlaT::dlaT, creating H37RvDpdhC and
H37RvDpdhCDdlaT::dlaT. Colonies were screened by PCR and confirmed by
Southern blotting. To create a strain lacking both DlaT and PdhC, we switched
the complementing plasmid out of the attB site of H37RvDpdhCDdlaT::dlaT
with an empty plasmid bearing a zeocin resistance cassette, pTCZ-MCS1,
creating H37RvDpdhCDdlaT pTCZ-mcs1 (DpdhCDdlaT).
To confirm deletion of lpdC, we digested genomic DNA from wild-type
H37Rv and knockout candidates with XmaI and NcoI, separated it by agarose
gel electrophoresis, and transferred it to a nylon membrane that was probed
with a 500-bp digoxygenin-labeled fragment containing the upstream lpdC
50 flanking fragment, revealing a 4.5 kb band for wild-type Mtb and a 2.7 kb
band for lpdC-deficient Mtb.
Genomic DNA from H37RvDpdhC and H37RvDpdhCDdlaT::dlaT was
digested with EcoRV and XmaI and transferred to a nylon membrane that
was probed with a fragment containing 300 bp of pdhB yielding a 1.5 kb frag-
ment for wild-type and a 3.5 kb fragment for pdhC-deficient Mtb upon
Southern blotting with the ECL Direct Nucleic Acid Labeling and Detection
System (Amersham).
Antisera to Lpd and PdhC
Recombinant Lpd purified as reported (Argyrou and Blanchard, 2001) was
used to immunize chickens. Recombinant PdhC purified as reported (Tian
et al., 2005b) was used to immunize rabbits.
Stress Assays
For nitrosative stress, Mtb strains were grown to mid-log phase and washed
twice in 7H9 acidified to pH 5.5 with HCl. Cultures were centrifuged at 120 g
for 10 min to remove clumps. Supernatants were adjusted to an OD580 =
0.1, NaNO2 was added, and CFUs were determined after 4 days. For oxidative
stress, Mtb strains prepared as above but in nonacidified medium werec.
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4 hr. For other stresses, Mtb strains prepared as above were adjusted to
OD580 = 0.1 and SDS or antibiotics were added. CFUs were determined after
1 hr with SDS and after 4 hr with lipophilic antibiotics. All experimentswere per-
formed in triplicate with serial dilution and plating on 7H11 agar, counting
CFUs after 4 weeks at 37C.
Mouse Infections
C57BL/6 wild-type and IFNg/ mice (Jackson Labs) were infected by using
an Inhalation Exposure System (Glas-Col). Early to mid-log phase Mtb was
washed once in PBS + 0.05% Tween 80 (PBST) and centrifuged at 120 g to
remove clumps. The inoculum (6 ml, adjusted to an OD580 = 0.002–0.005)
was nebulized for 40min. Lungs and spleenwere homogenized in PBS, serially
diluted, and plated on 7H11 agar. For mice infected with Lpd-deficient or DlaT/
PdhC-deficient Mtb, entire organ homogenates were plated on 7H11-OADC
plates, except in mice euthanized on days 64 and 164, in which the upper
left lobe was reserved for histology. Plates were incubated at 37C for 5 weeks
if no CFUs were detected earlier. In most experiments, the upper lobe of the
left lung was fixed in 4% paraformaldehyde for histopathology.
Macrophage Infections
Marrow cells were flushed from femurs of 8- to 10-week-old C57BL/6 mice
and incubated for 6 days at 37C, 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM) (GIBCO) with 10% heat-inactivated fetal calf serum, 20%
L929 fibroblast-conditioned medium, 1 mM sodium pyruvate (Mediatech
Inc.), 10 mMHEPES (GIBCO), and 0.58 g/L L-glutamine (Mediatech Inc.). Cells
were fed with the samemedium at day 4 and seeded in 48-well plates on day 6
(Ehrt et al., 2001). Where indicated, macrophages were stimulated with IFNg
(10 ng/ml, R&D Systems). Mid-log Mtb cultures were washed twice in PBST.
Clumps were removed by centrifugation at 120 g and the macrophages
were infected with 0.1 Mtb per macrophage. CFUs were assessed over
a period of 6 days (Ehrt et al., 2001).
Quantitative Real-Time PCR
We grew Mtb in standard medium starting at an OD580 of 0.05 for 14 and
28 days and added an equal volume of buffer containing guanidinium thiocy-
anate (4M), sodium lauryl sulfate (0.5%), trisodium citrate (25 mM), and 2-mer-
captoethanol (0.1 M). Cultures were pelleted, resuspended in TRIzol, and
bead-beaten three times. RNA was extracted and qRT-PCR was performed
by using gene-specific Taqman probes and primers (Biosearch Technologies).
Analysis of Intracellular Metabolites
Mtb was grown to mid-log phase in standard medium and diluted to an OD580
of 0.2. One milliliter of each culture was filtered through a nitrocellulose
membrane (0.22 mM, Millipore GSWP 02500). Mtb-bearing filters were placed
on individual 7H9 agar plates supplemented with 0.5% glycerol, 0.5% BSA,
0.2% dextrose, and 0.085% NaCl with the bacterial surface on top. Plates
were incubated at 37C in 5% CO2 for 14 and 28 days. Filters were flipped
onto a 1 ml ice-cold solution of 40% acetonitrile, 40% methanol, and 20%
water. Bacteria were scraped off the filter and lysed by bead-beating three
times. Intracellular metabolites and those that had leaked into the lysis solution
were pooled as described (de Carvalho et al., 2010a, 2010b). Metabolite abun-
dances were quantified by using a calibration curve generated with chemical
standards spiked into homologous mycobacterial extracts to correct for
matrix-associated ion-suppression effects. Protein was measured by using
the Bio-Rad DC assay (Bio-Rad). Ion counts of specific metabolites were
normalized to total protein. Statistical significance was assessed with the
Mann-Whitney t test (p < 0.02).
Immunoblotting and Immunoprecipitation
Mtb was grown to late stationary phase (28 days in culture) in standard
medium, pelleted, washed twice in PBST, and resuspended in potassium
phosphate buffer (KPi, 25 mM) containing EDTA (1 mM) and phenylmethane-
sulfonyl fluoride (PMSF) (1 mM). Lysates were prepared by bead-beating three
times and pelleting at 20,000 g. Proteins (15–30 mg) were separated by SDS-
PAGE and transferred to a nitrocellulose membrane. Antisera used were
anti-Lpd (1:5000); anti-PdhC (1:5000); anti-DlaT (1:10,000) (Bryk et al., 2002);
anti-proteasome component B (PrcB) (1:10,000) (Gandotra et al., 2007); orCellanti-lipoic acid (Calbiochem, 1:2500). Secondary antibodies used were
rabbit anti-chicken immunoglobulin Y (Promega, 1:5000) and donkey anti-
rabbit IgG (Amersham, 1:10,000). Lysates of late log-phase cultures of
DlpdC::FLAGlpdC, DdlaT::FLAGlpdC, H37Rv, and H37RvDdlaTwere adjusted
to 5 mg/ml with the lysis buffer, precleared with Sepharose beads for 1 hr, and
incubated with anti-FLAG M2 beads (SIGMA) at 4C overnight. Beads were
washed three times with wash buffer (WB300) containing Tris, pH 7.4
(20 mM), NaCl (300 mM), glycerol (10%), EDTA (0.2 mM), Triton X-100
(0.2%), PMSF (1 mM), and dithiothreitol (1 mM). The beads were then washed
withWB100 buffer containing only 100mMNaCl and eluted inWB100 contain-
ing 2xFLAG peptide (SIGMA) for SDS-PAGE and western blotting.
Enzyme Assays
Lysates of late log-phase cultures (1mg protein/ml) were incubated in cuvettes
at 37C in KPi (25 mM) with oxidized nicotinamide adenine dinucleotide
(1 mM), thiamine pyrophosphate (0.2 mM), coA (0.17 mM), MgCl (1 mM),
and 3M2OB (2mM) (Fluka). Production of reduced nicotinamide adenine dinu-
cleotide was monitored at 340 nm in a Uvikon XL spectrophotometer.
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